Coin info
Rank
Market Cap
Volume (24h)
Circulating Supply
Total Supply
Do you think the price will rise or fall?
Rise 40%
Fall 60%
Price perfomance
Depth of Market
Depth +2%
Depth -2%


PRICE
+9.59%
$1,308.67

PRICE
+8.57%
$0.09644

PRICE
+8.04%
$0.053

PRICE
+6.92%
$0.04348

PRICE
+6.65%
$0.02895
PRICE
+6.54%
$2.24

PRICE
+6.46%
$0.1826

PRICE
+6.4%
$0.055

PRICE
+6.29%
$0.004410

PRICE
+5.19%
$4.1

PRICE
+4.59%
$0.007306

PRICE
+4.36%
$0.4047

PRICE
+4.1%
$7.46

PRICE
+3.88%
$0.3909

PRICE
+3.73%
$0.2550

PRICE
+3.49%
$4,030.55

PRICE
+3.35%
$4,039.58
PRICE
+3.17%
$0.03155

PRICE
+3.12%
$0.9138

PRICE
+2.72%
$231.04

PRICE
+2.61%
$86.92

PRICE
+2.61%
$131.41

PRICE
+2.61%
$1.2

PRICE
+2.58%
$2,324.2

PRICE
+2.56%
$0.1608

VOL24
+2,091.97%
$1.03

VOL24
+939.13%
$0.04348

VOL24
+225.09%
$1.15

VOL24
+157.99%
$0.05021

VOL24
+132.06%
$0.09644

VOL24
+127.97%
$0.09875

VOL24
+106.06%
$108.94

VOL24
+103.76%
$0.9985

VOL24
+92.48%
$7.26
VOL24
+91.52%
$2.24

VOL24
+83.09%
$1.0000

VOL24
+82.28%
$1.29

VOL24
+78.29%
$0.004410

VOL24
+77.93%
$0.07618

VOL24
+62.63%
$0.9961

VOL24
+55.65%
$0.8737

VOL24
+48.92%
$0.9913

VOL24
+44.25%
$0.053

VOL24
+40.65%
$0.4620

VOL24
+40.26%
$0.9138

VOL24
+38.85%
$0.5920

VOL24
+38.18%
$0.9984

VOL24
+35.51%
$0.07095

VOL24
+32.91%
$75.4

VOL24
+31.94%
$0.055

PRICE
+9.59%
$1,308.67

PRICE
+8.57%
$0.09644

PRICE
+8.04%
$0.053

PRICE
+6.92%
$0.04348

PRICE
+6.65%
$0.02895
PRICE
+6.54%
$2.24

PRICE
+6.46%
$0.1826

PRICE
+6.4%
$0.055

PRICE
+6.29%
$0.004410

PRICE
+5.19%
$4.1

PRICE
+4.59%
$0.007306

PRICE
+4.36%
$0.4047

PRICE
+4.1%
$7.46

PRICE
+3.88%
$0.3909

PRICE
+3.73%
$0.2550

PRICE
+3.49%
$4,030.55

PRICE
+3.35%
$4,039.58
PRICE
+3.17%
$0.03155

PRICE
+3.12%
$0.9138

PRICE
+2.72%
$231.04

PRICE
+2.61%
$86.92

PRICE
+2.61%
$131.41

PRICE
+2.61%
$1.2

PRICE
+2.58%
$2,324.2

PRICE
+2.56%
$0.1608

VOL24
+2,091.97%
$1.03

VOL24
+939.13%
$0.04348

VOL24
+225.09%
$1.15

VOL24
+157.99%
$0.05021

VOL24
+132.06%
$0.09644

VOL24
+127.97%
$0.09875

VOL24
+106.06%
$108.94

VOL24
+103.76%
$0.9985

VOL24
+92.48%
$7.26
VOL24
+91.52%
$2.24

VOL24
+83.09%
$1.0000

VOL24
+82.28%
$1.29

VOL24
+78.29%
$0.004410

VOL24
+77.93%
$0.07618

VOL24
+62.63%
$0.9961

VOL24
+55.65%
$0.8737

VOL24
+48.92%
$0.9913

VOL24
+44.25%
$0.053

VOL24
+40.65%
$0.4620

VOL24
+40.26%
$0.9138

VOL24
+38.85%
$0.5920

VOL24
+38.18%
$0.9984

VOL24
+35.51%
$0.07095

VOL24
+32.91%
$75.4

VOL24
+31.94%
$0.055
Rise 40%
Fall 60%


$0.4921
#2636
$1,607,203
$126.75
1,000,000
1,000,000
What is the project about? VitaDAO, a decentralized autonomous organization, introduces VITA-FAST, an innovative funding model for longevity research. Leveraging the Ethereum blockchain, VITA-FAST are ERC-20 tokens, signifying fractional ownership of the Intellectual Property Non-Fungible Token (IP-NFT) from longevity research conducted at the Korolchuk Lab, Newcastle University. VITA-FAST token holders gain governance rights over the IP, democratizing the decision-making processes in scientific research. 1. What is the project about? The project is focused on discovering and developing therapeutic compounds that can reactivate autophagy in Npc1 -/- cells. This involves screening bioactive and commercial small molecules in cell survival assays to identify potential autophagy activators that are not cytotoxic. The project uses advanced techniques like luciferase-p6 clearance and Halo-GFP-LC3 orthogonal assays for this purpose. 2. What makes your project unique? The project's uniqueness lies in its approach to identifying novel compounds that can induce autophagy in NPC1 -/- cells, a crucial process for treating Niemann-Pick Type C disease. Unlike existing treatments, this project employs high-throughput screening methods and innovative assays to discover compounds with high chemical variability and no similarity to existing autophagy inducers, opening up possibilities for new iIP. 3. History of your project. The project, led by Dr. Korolchuk and his team at Newcastle University, has progressed from generating data on thousands of compounds using advanced screening assays to identifying lead compounds with potential autophagic properties. It has evolved to include the synthesis of derivatives of these compounds and is now moving towards drug translation processes, including pharmacokinetics and scalability studies. 4. What’s next for your project? The next steps involve screening third-generation compounds, conducting in vitro and in vivo models using patient